A vs VCYT: fair value comparison
Agilent Technologies, Inc. and Veracyte, Inc. · Updated 2026-10-19
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, A currently sits closer to the top of our ranking by discount to fair value. VCYT carries the stronger quality grade.
| A | VCYT | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $170.54 | $43.12 |
| 12-month range | $110.24–$175.55 | $30.01–$60.49 |
| Rank by discount to fair value | #62 of 108 Healthcare | #65 of 108 Healthcare |
| Quality grade | B | A |
| Leverage | Moderate | Low |
| Margin trend | Stable | Expanding |
| Revenue growth | Modest | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Mixed |
| 52-week position | The top quarter | The lower-middle quarter |
Full single-stock breakdowns: A fair value analysis · VCYT fair value analysis